MoneyWorks4Me

Clarification sought from GlaxoSmithKline Pharmaceuticals

08 Jun 2015 Evaluate

The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals with respect to news article appearing in Business Standard dated June 6, 2015 titled ‘CCI slaps Rs 64 crore fine on GlaxoSmithKline, Sanofi’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1852.50
Dr. Reddys Labs. 1146.30
Cipla 1360.10
Lupin 2047.00
Zydus Lifesciences 1108.50
View more..